All aspect of the emergency medical record including physician notes, nursing notes, and physician orders were used for completion of data extraction. Injury information was used to generate Abbreviated Injury Severity Scores . Follow-Up Assessments Follow-up assessments are completed at 6 weeks, 6 months, and 1 year post-enrollment with Inhibitors,research,lifescience,medical assessment made during a 4 week window for each follow-up time point (Additional File 3). Information collected at each follow-up is identical, except that drug and alcohol use is reassessed at only the 6 month and 1 year time points. Participants are able to
complete the interview online, by telephone, or by mail. Information packets are sent that remind participants that it is time to complete their next assessment. These packets include the actual questionnaires to be completed during the interview; if participants Inhibitors,research,lifescience,medical choose to complete their assessment via mail they can do so or they can follow along with the questionnaires
at home during a telephone interview. Follow up interviews are scheduled at a time (day or evening) that is convenient for the participant. Three and nine months after enrollment, participants also complete a contact information update via mail. Assessments collect detailed information regarding re-injury or new injury events, as well as information Inhibitors,research,lifescience,medical regarding involvement in a litigation or disability claim, missed work or other activities, somatic symptoms (including pain symptoms), psychological symptoms, and functional interference due to pain (Table (Table1).1). Inhibitors,research,lifescience,medical For any body region for which pain is reported, the patient is also asked whether the pain is due to (began after) the MVC. Health care utilization assessments are also evaluated and include: medication use; visits to the ED, ACY-1215 research buy primary physician, specialist physicians, or alternative medicine providers; and hospitalization. Inhibitors,research,lifescience,medical Participants are compensated $50, $60, and $70 after completing the 6 week, 6 month, and 1 year follow-up interviews, respectively.
Protection of Patient Privacy A number of methods are used to maintain the confidentiality of study data. A Certificate of Confidentiality has nearly been obtained from the National Institutes of Health to protect identifiable research information from forced disclosure . All research assistants involved in the study complete training in the protection of patient confidentiality through the Collaborative Institutional Training Initiative . Signed consent is obtained from all patients to perform all assessments and to allow future analysis of de-identified blood specimens. A unique patient identifier is used to link patient identifying information to results of questionnaires and genetic information, and all analyses are conducted on de-identified data. The study has been approved by the institutional review boards of all participating institutions.